Find a Pharmacy
Vertice Login
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends

RxInformer

Award-winning journal providing in-depth analysis on today’s most important topics

State of States

A roundup of regulatory activity around the country
Winter 2023/2024

Risky Business: Evolving Risks Across Workers’ Comp

A message from the Chief Executive Officer
Summer 2023

More than Skin-Deep: Untangling Topical Drug Classes and Costs

A breakdown of the diverse subcategories comprising dermatologicals prescribing and spend
Summer 2023

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

Healthe Leaders Share Insights

CEO Daryl Corr and SVP Todd Piscoitti were featured in WorkCompWire’s Leaders Speak series, while VP of Clinical Services, Silvia Sacalis’ recaps her National Comp presentation.
Nov 2025

New Osteoporosis Biosimilar Approved

Enoby™ (denosumab-qdbe) injections are a biosimilar of Prolia®, to help increase bone mass in those with high risk of fracture.
Oct 2025

The Injured Worker Patient in 3D: Driving More Personalized Care Through Strategic Formulary Design

With an effective formulary strategy, PBMs can ensure injured worker patients receive the most appropriate care and create better outcomes.
Oct 2025

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

Xeljanz Could Increase the Risk of Heart Problems and Cancer

New data from a safety trial creates concern surrounding the rheumatoid arthritis drug.
Feb 2021

COVID-19’s Impact on Opioid Prescribing Trends

A new report from IQVIA found that national MME dropped 17% from 2019 to 2020.
Jan 2021

IQVIA Reports on Telemedicine Trends and Opportunities

A new report explores how COVID-19 has impacted telemedicine, as well as opportunities for expansion.
Dec 2020
1 12 13 14 15 16 29

Whitepapers

lockmap-markermagnifiercrossmenucross-circle